Orchid Pharma Board Appoints Whole-Time Director, Cost Auditors

Orchid Pharma Ltd's Board of Directors convened on September 03, 2026, approving key appointments and strategic decisions. The board appointed Mr. Arjun Dhanuka as Whole-Time Director for a five-year term and M/s. J Karthikeyan & Associates as Cost Auditors for FY 2026-27, subject to member ratification. Additionally, the company announced the 33rd Annual General Meeting scheduled for September 29, 2026, with September 04, 2026, set as the cut-off date for AGM notice eligibility and September 22, 2026, for e-voting eligibility. The remote e-voting period will run from September 26 to September 28, 2026.